Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Kazia Therapeutics Ltd ADR stock

Learn how to easily invest in Kazia Therapeutics Ltd ADR stock.

Kazia Therapeutics Ltd ADR is a biotechnology business based in the US. Kazia Therapeutics Ltd ADR shares (KZIA) are listed on the NASDAQ and all prices are listed in US Dollars.

How to buy shares in Kazia Therapeutics Ltd ADR

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – KZIA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Kazia Therapeutics Ltd ADR stock price (NASDAQ: KZIA)

Use our graph to track the performance of KZIA stocks over time.

Kazia Therapeutics Ltd ADR shares at a glance

Information last updated 2022-09-24.
Latest market close$1.12
52-week range$1.04 - $12.28
50-day moving average $2.02
200-day moving average $5.47
Wall St. target price$11.30
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.81

Buy Kazia Therapeutics Ltd ADR shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Kazia Therapeutics Ltd ADR stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Kazia Therapeutics Ltd ADR price performance over time

Historical closes compared with the close of $1.12 from 2022-09-29

1 week (2022-09-23) -0.88%
1 month (2022-09-01) -19.42%
3 months (2022-07-01) -73.27%
6 months (2022-04-01) -86.02%
1 year (2021-10-01) -89.95%
2 years (2020-09-29) -83.41%
3 years (2019-10-01) 3.66
5 years (2017-09-29) 3

Kazia Therapeutics Ltd ADR financials

Revenue TTM $10,000
Gross profit TTM $10,000
Return on assets TTM -33.41%
Return on equity TTM -87.27%
Profit margin 0%
Book value $1.34
Market capitalisation $21 million

TTM: trailing 12 months

Kazia Therapeutics Ltd ADR share dividends

We're not expecting Kazia Therapeutics Ltd ADR to pay a dividend over the next 12 months.

Have Kazia Therapeutics Ltd ADR's shares ever split?

Kazia Therapeutics Ltd ADR's shares were split on a 1:4 basis on 14 July 2017. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Kazia Therapeutics Ltd ADR shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Kazia Therapeutics Ltd ADR shares which in turn could have impacted Kazia Therapeutics Ltd ADR's share price.

Kazia Therapeutics Ltd ADR share price volatility

Over the last 12 months, Kazia Therapeutics Ltd ADR's shares have ranged in value from as little as $1.04 up to $12.28. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Kazia Therapeutics Ltd ADR's is 2.8762. This would suggest that Kazia Therapeutics Ltd ADR's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Kazia Therapeutics Ltd ADR overview

Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various forms of cancer. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. The company was incorporated in 1994 and is based in Sydney, Australia. .

Frequently asked questions

What percentage of Kazia Therapeutics Ltd ADR is owned by institutions?
Currently 2.187% of Kazia Therapeutics Ltd ADR shares are held by institutions.
When does the fiscal year end for Kazia Therapeutics Ltd ADR?
Kazia Therapeutics Ltd ADR's fiscal year ends in June.
Where is Kazia Therapeutics Ltd ADR based?
Kazia Therapeutics Ltd ADR's address is: Three International Towers, Sydney, NSW, Australia, 2000
What is Kazia Therapeutics Ltd ADR's ISIN number?
Kazia Therapeutics Ltd ADR's international securities identification number is: US48669G1058
What is Kazia Therapeutics Ltd ADR's CUSIP number?
Kazia Therapeutics Ltd ADR's Committee on Uniform Securities Identification Procedures number is: 48669G105

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site